Search alternatives:
significant inverse » significant adverse (Expand Search), significant increase (Expand Search), significant interest (Expand Search)
inverse decrease » rivers decreased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
Showing 1 - 20 results of 5,863 for search '(( significant ((non decrease) OR (mean decrease)) ) OR ( significant inverse decrease ))', query time: 0.61s Refine Results
  1. 1
    Elevated concentrations of serum MMA among participants with decreased cognitive performance.

    Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Summary of non-randomized studies.

    Summary of non-randomized studies. by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Methodological items for non-randomized studies (MINORS).

    Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Madrasin decreases transcription of protein-coding genes.

    Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

    Published 2024
    Save to List
    Saved in:
  5. 5
    Most significant muscle activation values.

    Most significant muscle activation values. by María Benito-de-Pedro (22057468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Maximum IFN concentrations are decreased in severe patients.

    Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Annual treatment frequencies in recurrence and non-recurrence groups.

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Significant repeated measurements sEMG outcomes.

    Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Significant single measurement sEMG outcomes.

    Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Annual number of outpatient visits in recurrence and non-recurrence groups.

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.

    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon.

    Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. by Daisuke Sugahara (2047696)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye.

    Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.

    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories.

    Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups.

    Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients.

    Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models.

    Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Flow Chart of Study Participant Selection.

    Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: